Sortilin is a 95-kDa protein related to circulating cholesterol. It is found inside different cell types and circulating in blood and it has been associated with the risk of atherosclerosis development and cardiovascular diseases. The goal of this observational study is to evaluate the potential use of circulating sortilin as a biomarker of vascular adverse outcomes in patients with peripheral artery disease (PAD) and chronic limb-threatening ischemia (CLTI) requiring a procedure of endovascular revascularization. The main questions it aims to answer are: * association between sortilin serum levels and risk of restenosis after lower extremity revascularization. * association between sortilin serum levels and acute limb ischemia, major vascular amputations, and limb-threatening ischemia needing for urgent revascularization after lower extremity revascularization. Patients with PAD and CLTI requiring lower extremity endovascular revascularization will undergo blood sampling for the dosage of circulating sortilin before the endovascular procedure. Incidence of restenosis and acute limb ischemia, major vascular amputations, and limb-threatening ischemia needing for urgent revascularization will be collected in a 12-months follow-up and will be associated with sortilin serum levels at baseline.
Study Type
OBSERVATIONAL
Enrollment
207
Fondazione Policlinico Universitario A. Gemelli IRCCS
Rome, Italy
RECRUITINGCorrelation between sortilin serum levels before endovascular revascularization and incidence of restenosis
To evaluate the association between sortilin serum levels before endovascular revascularization and restenosis during the follow-up period.
Time frame: 12-months follow-up
Correlation between sortilin serum levels before endovascular revascularization and incidence of acute limb ischemia
To evaluate the association between sortilin serum levels before endovascular revascularization and acute limb ischemia during the follow-up period.
Time frame: 12-months follow-up
Correlation between sortilin serum levels before endovascular revascularization and incidence of amputations
To evaluate the association between sortilin serum levels before endovascular revascularization and amputations during the follow-up period.
Time frame: 12-months follow-up
Correlation between sortilin serum levels before endovascular revascularization and chronic limb-threatening ischemia needing for urgent revascularization
To evaluate the association between sortilin serum levels before endovascular revascularization and limb-threatening ischemia needing for urgent revascularization during the follow-up period.
Time frame: 12-months follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.